Page last updated: 2024-12-07

acid green 50

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID91525
CHEMBL ID2028349
SCHEMBL ID341870
SCHEMBL ID24354
MeSH IDM0585829

Synonyms (91)

Synonym
nsc-71959
ccris 1908
nsc 71959
lissamine green b
green 5
methanaminium, n-(4-((4-(dimethylamino)phenyl)(2-hydroxy-3,6-disulfo-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methyl-, hydroxide, inner salt, monosodium salt
n-(4-((4-(dimethylamino)phenyl)(2-hydroxy-3,6-disulfo-1-naphthale- nyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methylmethanaminium hydroxide, inner salt, monosodium salt
green bs
food green s
schultz nr. 836 [german]
brilliantsaeure gruen bs [german]
hydrogen (4-(4-(dimethylamino)-alpha-(2-hydroxy-3,6-disulphonato-1-naphthyl)benzylidene)cyclohexa-2,5-dien-1-ylidene)dimethylammonium, monosodium salt
einecs 221-409-2
ammonium, (4-(p-(dimethylamino)-alpha-(2-hydroxy-3,6-disulfo-1-naphthyl)benzylidene)-2,5-cyclohexadien-1-ylidene)dimethyl-, hydroxide, inner salt, sodium salt
e 142
ci 44090
zelen kysela bs [czech]
zelen potravinarska 4 [czech]
zelen kysela 50 [czech]
nsc 11237
acid green 50
brilliant acid green bs
n-(4-((4-(dimethylamino)phenyl)(2-hydroxy-3,6-disulfo-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methylmethanaminium, hydroxide, inner salt, monosodium salt
methanaminium, n-[4-[[4-(dimethylamino)phenyl](2-hydroxy-3,6-disulfo-1-naphthalenyl)methylene]-2,5-cyclohexadien-1-ylidene]-n-methyl-, inner salt, monosodium salt
c.i. 44090
nsc-11237
c.i. acid green 50, monosodium salt
vondacid green s
3087-16-9
calcocid green sb
kiton green s
unitertracid green bs
water green sx
erio green s
calcocid green s
green s
edicol supra green bs
acid brilliant green bs
edicol supra green b
c.i. acid green 50
c.i. food green 4
12078 green
vert acide brilliant bs
acilan green bs
pontacyl green son and s
calocid green sb
naphthazine green s
lissamine green bn
acid leather green s
pharmacid green s
hexacol green s
calocid green s
NCGC00166248-01
lissamine(tm) green b, dye content 60 %
G0250
cas-3087-16-9
dtxsid4046577 ,
tox21_112374
dtxcid2026577
AKOS024319596
brilliantsaeure gruen bs
unii-9b7e8y9d0x
schultz nr. 836
methanaminium, n-(4-((4-(dimethylamino)phenyl)(2-hydroxy-3,6-disulfo-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methyl-, inner salt, monosodium salt
zelen kysela bs
zelen kysela 50
methanaminium, n-(4-((4-(dimethylamino)phenyl)(2-hydroxy-3,6-disulfo-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methyl-, inner salt, sodium salt (1:1)
9b7e8y9d0x ,
zelen potravinarska 4
FT-0627882
AKOS015903470
green s [mi]
acid green 50 [inci]
acid green rs
ci 44090 [inci]
acid green bs
green s (e 142)
SCHEMBL341870
SCHEMBL24354
CHEMBL2028349
mfcd00012117
green s, analytical standard
J-018175
sodium 4-((4-(dimethylamino)phenyl)(4-(dimethyliminio)cyclohexa-2,5-dienylidene)methyl)-3-hydroxynaphthalene-2,7-disulfonate
Q420143
1264298-48-7
sodium;4-[[4-(dimethylamino)phenyl]-(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]-3-hydroxynaphthalene-2,7-disulfonate
acid green 50 100 microg/ml in acetonitrile
D90736
sodium 4-((4-(dimethylamino)phenyl)(4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene)methyl)-3-hydroxynaphthalene-2,7-disulfonate
AS-81513

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Haematological examination revealed a transitory mild anaemia at the highest dose level, whilst no findings indicative of a toxic effect were found in the renal concentration tests or the serum analyses."( Short-term toxicity study of Green S in rats.
Clode, SA; Cottrell, RC; Gangolli, SD; Gaunt, IF; Hendy, RJ, 1987
)
0.27
" There were no adverse effects of treatment on body-weight gain, food and water consumption or on the general condition of the animals."( Three-generation toxicity study of rats ingesting Green S in the diet.
Creasy, DM; Gaunt, IF; Moorhouse, SR, 1987
)
0.27

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" No differences between the dose-response curves of furosemide, bumetanide, or piretanide could be demonstrated."( Effect of diuretics on the tubuloglomerular feedback response.
Brunkhorst, R; Franke, H; Gutsche, HU; Müller-Ott, K; Niedermayer, W, 1984
)
0.27
"A randomized, double-masked, multicenter, placebo-controlled, parallel-group, dose-response phase II study."( Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Awamura, S; Kinoshita, S; Nakamichi, N; Oshiden, K; Suzuki, H; Yokoi, N, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (5 Product(s))

Product Categories

Product CategoryProducts
Vitamins & Supplements3
Household Essentials2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Ancient Nutrition Organic SuperGreens Powder -- 7.05 ozAncient NutritionVitamins & SupplementsGreens2024-11-29 10:47:42
Orgain Vegan Organic Greens & 50 Superfoods Powder - 1B Probiotics Berry -- 0.62 lbsOrgainVitamins & SupplementsGreens2024-11-29 10:47:42
Orgain Vegan Organic Greens & 50 Superfoods Powder - 1B Probiotics Original -- 0.62 lbsOrgainVitamins & SupplementsGreens2024-11-29 10:47:42
Stonewall Kitchen Liquid Hand Soap Herbes de Provence -- 16.9 fl ozStonewall KitchenHousehold Essentialsgreen 5, vitamin E, vitamin E, coco betaine2024-11-29 10:47:42
Stonewall Kitchen Liquid Hand Soap Lake House -- 16.9 fl ozStonewall KitchenHousehold Essentialsgreen 5, red 40, vitamin E, vitamin E, coco betaine2024-11-29 10:47:42

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency10.87520.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency13.42160.000221.22318,912.5098AID743042; AID743054
estrogen nuclear receptor alphaHomo sapiens (human)Potency16.66340.000229.305416,493.5996AID743079; AID743080; AID743091
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency26.60320.001723.839378.1014AID743083
nuclear receptor subfamily 1, group I, member 2Rattus norvegicus (Norway rat)Potency17.78280.10009.191631.6228AID1346983
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency16.10960.000323.4451159.6830AID743065; AID743067
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency14.96010.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency14.96010.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (26.67)18.7374
1990's8 (17.78)18.2507
2000's9 (20.00)29.6817
2010's15 (33.33)24.3611
2020's1 (2.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.26 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (6.38%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (91.49%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]